Category: Craig Venter
Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19
Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and Drug Administration to begin early-stage clinical trials on a potential treatment for COVID-19. The company, which has raised at least $290 million to date (according to Crunchbase), uses “Natural Killer”…
Read MoreRecent Posts
- Walmart just launched a huge flash sale: shop the 11 best deals before they’re gone
- Yale Approach Smart Lock Review: Magical Door-Unlocking Powers
- Assassin’s Creed Mirage won’t be getting any DLC, but the director has ideas on how to extend the story of protagonist Basim
- Ford looks to future EV breakthroughs — and smaller cars — to staunch the bleeding
- One of Fallout season 1’s most heart-breaking finale scenes was reshot because ‘it didn’t feel right’, star says
Archives
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- December 2011